Today's briefing tracks further escalations in the ongoing U.S.-Iran military conflict, a significant international move to sanction Israeli settlers, and a pair of major medical breakthroughs in preventing HIV and treating sickle cell anemia.
In a major escalation of the direct U.S.-Iran military conflict we've been tracking, the two nations exchanged new strikes following the downing of a US Apache helicopter near the Strait of Hormuz. Expanding on their recent missile salvos against U.S. facilities in Bahrain and Kuwait, Iran's latest response also targeted locations in Jordan. President Trump warned Iran it would 'pay the price' for delaying negotiations, prompting Iran to vow it would 'leave no attack or threat unanswered.'
Why it matters
The addition of a downed U.S. helicopter and expanded targeting into Jordan pushes this beyond the initial post-ceasefire exchanges, dangerously heightening the risk of a full-scale regional war with immediate consequences for global energy supplies.
A coalition of six countries—Australia, the UK, Canada, France, Norway, and New Zealand—has issued new joint sanctions on Israeli settlers and entities involved in violence against Palestinians in the West Bank. The measures notably target Israeli Finance Minister Bezalel Smotrich, representing a significant escalation of international pressure on Israel's policies in the occupied territories.
Why it matters
These coordinated sanctions by key U.S. allies signal growing international condemnation of Israel's settlement policies and could significantly impact diplomatic relations and future peace efforts in the region.
Phase 3 clinical trials for Lenacapavir, a new HIV-prevention drug administered as an injection every six months, have shown nearly 100% efficacy in preventing new infections. The trials involved over 8,000 participants and proved far more effective than daily pills, largely due to better adherence and reduced stigma.
Why it matters
This result marks a potential game-changer in HIV prevention, offering a highly effective and convenient alternative that could significantly accelerate the global fight against the virus, especially in vulnerable populations.
A decade-long clinical trial in sub-Saharan Africa has found that a higher dose of the common drug hydroxyurea reduced mortality from sickle cell anemia in children by 80%. The study, known as the NOHARM trial, also showed the treatment improved growth and development, challenging previous assumptions about the drug's effectiveness in low-resource settings.
Why it matters
This breakthrough offers a highly effective, accessible, and affordable treatment that could transform the lives of millions of children with sickle cell anemia in regions where the disease is most prevalent.
The U.S. Congress has passed a $70 billion funding bill for President Trump's immigration agenda, largely along party lines. The bill, now signed into law, allocates $38 billion for ICE and $26 billion for Border Patrol, securing funding for the administration's enforcement policies through fiscal year 2029.
Why it matters
This legislation solidifies the administration's hardline immigration and border security policies for years to come, independent of near-term election outcomes, and underscores the deep partisan divisions on the issue.
Artist Eric N. Mack has opened a new exhibition, 'RARE ESSENCE,' at the Speed Art Museum, using textiles and color to create an immersive installation in the museum's Gheens Court. Mack is known for blurring the lines between painting, sculpture, and fashion, with his work resonating with the legacy of artist Sam Gilliam.
Why it matters
For a painter, this exhibition highlights a key contemporary artist who is pushing the definition of painting into three-dimensional, architectural space, offering a compelling look at innovative material and spatial practices.
Google Arts & Culture has partnered with the Exploratorium and artist Stefanie Posavec to create 'See in CMYK,' an interactive digital artwork. The project uses Google's Gemini AI to transform user photos into images made of icons representing the CMYK printing process, bridging art, science, and AI.
Why it matters
This collaboration provides a tangible example of how AI can be a practical tool for artistic creation and public engagement, moving beyond simple image generation to offer a new way to experience creative processes.
US-Iran Conflict Escalates Following the downing of a US helicopter, the U.S. and Iran have exchanged direct military strikes, with Iran targeting U.S. bases in multiple Gulf countries and President Trump threatening further action, significantly raising the risk of a wider regional war.
International Pressure on Israel Mounts A coalition of six Western nations, including the UK and France, has imposed joint sanctions on Israeli settlers involved in violence, while a UN report details abuses by both Israeli settlers and Hamas forces, signaling increased global scrutiny.
Breakthroughs in Preventative and Accessible Medicine Major clinical trial results show a twice-yearly injection is nearly 100% effective at preventing HIV, while a separate decade-long study in Africa found a common drug dramatically reduces mortality for children with sickle cell anemia, highlighting advances in both cutting-edge and accessible treatments.
What to Expect
2026-06-15—G7 summit begins in France, with a likely meeting between President Trump and Indian PM Modi on the sidelines.
2026-06-16—The Royal Academy of Arts Summer Exhibition opens in London.
2026-07-07—NATO Leaders Summit begins in Ankara, Turkey.
How We Built This Briefing
Every story, researched.
Every story verified across multiple sources before publication.
🔍
Scanned
Across multiple search engines and news databases
437
📖
Read in full
Every article opened, read, and evaluated
146
⭐
Published today
Ranked by importance and verified across sources
7
— The Studio View
🎙 Listen as a podcast
Subscribe in your favorite podcast app to get each new briefing delivered automatically as audio.
Apple Podcasts
Library tab → ••• menu → Follow a Show by URL → paste